Dosidal · Switzerland

Respreeza, Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:65337 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 65337
atc: B02AB02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2016-01-21
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: B02AB02
authorisation_number: 65337
form: PULMI
holder: CSL Behring AG
holder_partner_nr: 1001745
it_number: 06.01.1.
name: Respreeza, Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
sw4Uzb6sIH0EGR4T9f7Fy7ZUwq_TrPIZZ0RMT0gxJJeKKnU69XOCC1ELr4EG61tLQsQMzntyzVktc4Yzc0Djgw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:65337 · Same medicine in other markets · Dosidal